The aim was to analyze the association between selected patient variables and health-related quality of life 6 months after surgery for lung cancer. Methods: In a prospective population-based cohort study, Short Form 36 (SF-36) was used to assess quality of life before and 6 months after surgery for lung cancer. The change in SF-36 summary and subscale scores were used to categorize quality of life in two groups (worse or stable/improved) at 6 months compared with baseline. Logistic regression models adjusting for potential confounding factors were used to analyze the association between patient variables and quality of life 6 months after surgery. Results: A baseline SF-36 questionnaire was completed by 249 patients. Nonresponders at 6 months (n ϭ 36) were excluded, and 14 patients who died before 6 months follow-up remained in the study, leaving 213 patients available for analysis. Gender, comorbidity, occurrence of postoperative complications, and tumor stage were not associated with the physical aspect of quality of life 6 months after surgery. The extent of resection, age, and adjuvant therapy was significantly associated with a clinically relevant decline in the SF-36 physical component summary score 6 months postoperatively. No patient variables were predictive of a decline in the mental component summary score.
A lthough surgical resection is the best treatment for localized cancer of the lung, a large operation may have impact on the health-related quality of life (QOL), both early after surgery and in the long run. There are conflicting data regarding changes in QOL during the first postoperative year [1] [2] [3] [4] [5] [6] ; however, current evidence suggests long-lasting limitations in the physical domain, but a partial recovery of mental or emotional capabilities. [7] [8] [9] [10] Risk estimation for inhospital death after pulmonary resection can be performed using the Thoracoscore model. 11, 12 However, in addition to information regarding risk of death or postoperative complications, patients require information regarding the risk of experiencing a significant reduction in their QOL. 13 Objective functional measures such as tests of lung function or exercise capacity do not satisfactorily predict QOL after surgery, 3,14 -16 and it is reasonable to conclude that it is necessary to use a validated instrument designed for QOL assessment to improve the level of understanding in this field.
We performed a prospective population-based cohort study to investigate health-related QOL at baseline and 6 months after lung surgery. This exploratory study examines the hypothesis that a clinically relevant decline in certain aspects of health-related QOL can be predicted by factors known before or early after surgery. The aim was to analyze the association between selected patient and tumor characteristics and QOL 6 months after surgery for lung cancer.
MATERIALS AND METHODS
From April 2006 to April 2008, 249 patients scheduled for lung surgery at the Karolinska University Hospital were included in a prospective population-based cohort study. Karolinska University Hospital is the only referral center for thoracic surgery in Stockholm County with an approximate population of 2 million.
Health-related QOL was assessed with the use of the Medical Outcomes Study 36-Item Short Form 36 (SF-36) questionnaire (Swedish Version 1.0). 17, 18 The SF-36 evaluates eight dimensions of health: physical functioning, role limitations due to physical problems, bodily pain, vitality, general health perception, social function, role limitations due to emotional problems, and mental health. Scores for each domain range from 0 to 100, with higher scores indicating better health status. Also, the SF-36 provides summary scales for overall physical and mental health-related QOL with the use of norm-based methods. 19 Again, higher scores indicate better health status.
All patients completed the baseline SF-36 questionnaire. Most patients completed the questionnaire on the day before surgery, and a small number of patients completed the questionnaire 2 to 4 days before surgery. Six months after the operation, the SF-36 questionnaire was mailed to the patients, and they were asked to fill out and return the questionnaire by mail. A reminder was sent out after 1 month to those patients who had not returned the second questionnaire, and a final reminder was sent 1 month later.
Patient and tumor characteristics and operative and postoperative details were prospectively collected and entered into a database.
The study was approved by the regional Human Research Ethics Committee, Stockholm, Sweden (Dnr: 2006/ 359-31/3). Informed consent was obtained from all patients.
Statistical Analyses
For the purpose of this study, the SF-36 summary and subscale scores were dichotomized into "stable or improved" versus "worse." Patients with a summary score reduction of 10% or more were categorized as worse, and otherwise as stable or improved. Patients with a subscale score reduction of 10 points or more were categorized as worse, and otherwise as stable or improved. Moreover, patients who died before reaching 6 months of follow-up, and thus unable to complete the second questionnaire, were categorized as worse. Logistic regression models were used to analyze associations between patient variables and QOL 6 months after surgery. We report OR and 95% confidence intervals (CIs). A final multivariable model was created, adjusting for age (two groups: younger or older than 65 years), gender, comorbidity, extent of resection (three groups: pneumonectomy, lobectomy, or sublobar resection), postoperative complication, adjuvant therapy, and tumor stage (two groups: stage 0 to I or stage II to III), and the corresponding baseline SF-36 summary or subscale score as a continuous variable. If the patients had any comorbidity, they were classified as "Comorbidity: Yes", and otherwise as "Comorbidity: No." Comorbidity was defined as the presence of any of ischemic heart disease, hypertension, congestive heart disease, diabetes mellitus, peripheral vascular disease, or cerebrovascular disease. Ischemic heart disease was defined as a history of angina pectoris, myocardial infarction, or revascularization procedure (coronary artery bypass surgery or percutaneous coronary intervention). Hypertension was defined as a history of high blood pressure requiring medication. Congestive heart disease was defined as a history of heart failure or left ventricular ejection fraction less than 0.5. Diabetes mellitus was defined as diabetes requiring insulin or oral antidiabetics. Peripheral vascular disease was defined as a history of claudication, carotid stenosis, or abdominal aneurysm. Cerebrovascular disease was defined as a history of stroke or transient ischemic attack. If the patients had any complication, they were classified as Complication: Yes, and otherwise as Complication: No. Complication was defined as any of the following postoperative complications: new onset atrial fibrillation, prolonged air leak (chest tubes in place for more than 5 days), pneumonia, reintubation, reoperation, or hospital stay of 8 days or more. Statistical analyses were performed using IBM SPSS Statistics 19 (IBM; Armonk, NY).
RESULTS

Study Population
We included 249 patients who completed the baseline SF-36 questionnaire. During 6 months of follow-up, 14 patients died and remained in the study categorized as worse in all summary and subscale score groups. For various reasons, 36 patients did not complete the second questionnaire, so the total study population for final analysis was 213 patients, and the dropout rate was 14% (36/249).
The characteristics of the study population are presented in Table 1 . Operation type, postoperative data, tumor stage, and histopathology are shown in Table 2 . The mean age of the study population was 65 years, and half were women. The majority underwent lobectomy and the most common histopathology was adenocarcinoma. About one third had adjuvant radio-or chemotherapy. Eleven patients underwent video-assisted thoracoscopic surgery. All other patients had a muscle-sparing posterolateral thoracotomy. Postoperative management included thoracic epidural analgesia.
Associations Between Patient Variables and SF-36 Summary Scores
Fifty-nine percent of the patients reported worse physical component summary score, and 33% reported worse mental component summary score 6 months after surgery compared with baseline (Table 3) . Gender, comorbidity, occurrence of postoperative complications, and tumor stage were not significantly associated with a reduction in the physical aspect of QOL 6 months after surgery. However, the extent of resection (lobectomy OR: 2.29, 95% CI: 1.02-5.17 and pneumonectomy OR: 5.60, 95% CI: 1.29 -24.2), age older than 65 years (OR: 1.95, 95% CI: 1.02-3.71), and adjuvant therapy (OR: 2.23, 95% CI 1.01-4.90) were significantly associated with a worse physical aspect of QOL 6 months postoperatively. There were no significant associa- (14) a Smoking status was divided into three categories: current, former, and never smoker. Current smoker was defined as an active smoker or a person who had stopped smoking within 1 year of surgery. Former smoker was defined as a previous smoker who had stopped smoking more than 1year before surgery. Never smoker was defined as a person who had never been an active smoker.
tions between any of the patient variables and worse mental aspect of QOL 6 months after surgery (Table 3 ).
Associations Between Patient Variables and SF-36 Subscale Scores
Between 34 and 52% of the patients reported worse QOL according to the SF-36 subscale scores 6 months after surgery compared with baseline (Table 4 ). Gender, comorbidity, and tumor stage were not significantly associated with a clinically relevant reduction in any of the SF-36 subscales 6 months after surgery. There was a significantly higher risk for deterioration in the physical role functioning subscale in patients older than 65 years compared with younger patients (OR: 3.13, 95% CI: 1.63-6.00 (Table 4 ).
DISCUSSION
The main findings were that patients who underwent either lobectomy or pneumonectomy compared with a less extensive resection, or were older than 65 years, or received adjuvant therapy compared with those who did not, had a higher risk for a clinically relevant decline in the physical aspect of QOL 6 months after surgery for lung cancer. Gender, comorbidity, occurrence of postoperative complications, and tumor stage were not significantly associated with a reduction in the physical aspect of QOL. None of the variables in the model was significantly associated with a clinically relevant reduction in the mental aspect of QOL. Patients who received adjuvant therapy had a significantly higher risk for a clinically relevant decrease in QOL in four of the SF-36 subscales, and the extent of resection was associated with a higher risk for a worsening in four of the SF-36 subscales. A postoperative complication was associated with an increased risk for a decline in three of the SF-36 subscales, and age older than 65 years predicted a meaningful reduction in one of the SF-36 subscales. Tumor stage, preoperative comorbidity, and gender were not associated with a clinically relevant decrease in any of the SF-36 subscales.
The prospective population-based design of our study, together with a high response rate, offered a reduced risk of selection bias and enhanced the external validity. However, we cannot completely rule out that the nonresponding patients at 6 months to a limited extent could have influenced the results. Another strength was the longitudinal design, making it possible to analyze the change in QOL before and 6 months after surgery, while adjusting for the corresponding baseline summary or subscale score in the regression models. We defined a clinically relevant worsening in QOL as a SF-36 summary score increase of 10% or more between baseline and 6 months after surgery. However, there is no universal method for defining the clinical significance or even the minimally important difference of QOL data. 20 One way of defining a clinically significant change in QOL is a difference score that is large enough to have an implication for the patient's treatment or care. 21 Other investigators have used an analogous definition of a clinically relevant difference in a large randomized clinical trial. 22 Several studies have investigated the effect of a single variable on postoperative QOL: age, 1, 4, 23, 24 gender, 25 smoking cessation, 26 and extent of resection. 2, 8, 27, 28 On the other hand, only a few studies have focused on identifying predictors for QOL after lung surgery. 29, 30 Pompili et al. assessed QOL using SF-36 in 172 patients before and 3 months after lung surgery and derived predictive equations estimating the decline in postoperative QOL. 30 The equation predicting the risk of a decline in the physical component summary score contained three SF-36 subscale scores: physical functioning, 29 Our finding of an increased risk for a worse physical aspect of QOL among patients receiving adjuvant therapy is contrasting to prior studies. Handy 5 reported that adjuvant therapy did not adversely affect postoperative QOL at follow-up 6 months after surgery, and other investigators showed that patients who had surgery in combination with adjuvant chemotherapy had equivalent EQ-5D utility score compared with patients receiving surgery alone. 31 Significantly worse postoperative QOL after pneumonectomy compared with lobectomy has been shown consistently by different groups, 2, 8, 27, 28 and our finding that the extent of surgical resection was a significant risk factor for a clinically relevant decrease in the physical aspect of QOL was therefore in line with prior research.
In conclusion, we found that the extent of surgery, age, and adjuvant therapy, was predictive of a reduced postoperative QOL 6 months after lung surgery. Other factors, i.e., gender, comorbidity, postoperative complications, and tumor stage, were not associated with a higher risk for impaired postoperative QOL. Our results were consistent with the hypothesis that a clinically relevant decline in certain aspects of health-related QOL can be predicted by factors know before or early after surgery, but further studies are needed to confirm these findings and to explore possible mechanisms. Worse QOL was defined as a subscale score reduction of 10 points or more, otherwise QOL was considered stable or improved.
